Natixis Advisors LLC Sells 22,308 Shares of Tenet Healthcare Co. (NYSE:THC)

Natixis Advisors LLC trimmed its position in shares of Tenet Healthcare Co. (NYSE:THC - Free Report) by 55.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,640 shares of the company's stock after selling 22,308 shares during the quarter. Natixis Advisors LLC's holdings in Tenet Healthcare were worth $2,226,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. FMR LLC grew its holdings in shares of Tenet Healthcare by 88.0% in the third quarter. FMR LLC now owns 7,700,693 shares of the company's stock valued at $1,279,855,000 after acquiring an additional 3,604,161 shares in the last quarter. Wealthfront Advisers LLC purchased a new stake in shares of Tenet Healthcare during the 4th quarter valued at $69,059,000. Geode Capital Management LLC raised its stake in shares of Tenet Healthcare by 23.6% during the 3rd quarter. Geode Capital Management LLC now owns 2,044,667 shares of the company's stock worth $339,893,000 after purchasing an additional 390,316 shares during the period. Raymond James Financial Inc. purchased a new stake in Tenet Healthcare during the fourth quarter worth about $49,001,000. Finally, Iron Triangle Partners LP bought a new stake in Tenet Healthcare in the third quarter worth about $51,346,000. Institutional investors own 95.44% of the company's stock.

Insider Activity

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the transaction, the director now directly owns 27,378 shares in the company, valued at $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.93% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Cantor Fitzgerald reissued an "overweight" rating and set a $177.00 price objective on shares of Tenet Healthcare in a report on Thursday, February 13th. The Goldman Sachs Group lowered Tenet Healthcare from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $196.00 to $140.00 in a report on Monday, December 16th. TD Cowen began coverage on shares of Tenet Healthcare in a research report on Wednesday, February 26th. They set a "buy" rating and a $175.00 target price for the company. Barclays lowered their price target on shares of Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating on the stock in a research report on Thursday, February 13th. Finally, JPMorgan Chase & Co. reiterated an "overweight" rating and issued a $175.00 price objective on shares of Tenet Healthcare in a research note on Tuesday, December 17th. Three research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, Tenet Healthcare has a consensus rating of "Moderate Buy" and an average target price of $163.94.

Tenet Healthcare Price Performance

Shares of THC stock traded up $1.37 during trading on Thursday, hitting $134.41. The company had a trading volume of 1,368,382 shares, compared to its average volume of 1,517,464. Tenet Healthcare Co. has a 52 week low of $90.03 and a 52 week high of $171.20. The stock has a market capitalization of $12.79 billion, a price-to-earnings ratio of 4.17, a price-to-earnings-growth ratio of 1.02 and a beta of 2.06. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. The stock's 50-day moving average is $132.35 and its two-hundred day moving average is $142.70.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. As a group, analysts predict that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.